Fluorinated 3-(2-Oxo-3-(3-Arylpropyl)Imidazolidin-1-yl)-3-Arylpropanoic Acid Derivatives
申请人:SciFluor Life Sciences, LLC
公开号:US20140221410A1
公开(公告)日:2014-08-07
The invention relates to fluorinated compounds and their use as integrin receptor antagonists. Novel fluorinated 3-(2-oxo-3-(3-arylpropyl)imidazolidin-1-yl)-3-arylpropanoic acid derivatives and pharmaceutically acceptable salts or solvates thereof and their use are described.
这项发明涉及
氟化合物及其作为整合素受体拮抗剂的用途。描述了新型
氟化3-(2-氧-3-(3-芳基丙基)
咪唑啉-1-基)-3-芳基
丙酸衍
生物及其药用可接受盐或溶剂,以及它们的用途。